This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: H Bion Co., Ltd.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Youn-Young Hwang: Innovator in Stem Cell Research
Introduction
Youn-Young Hwang is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of stem cell research, particularly in the area of embryonic stem cells. With a total of 2 patents, Hwang's work has the potential to impact regenerative medicine and therapeutic applications.
Latest Patents
Hwang's latest patents include groundbreaking innovations in the production of neuro-progenitor cells. One of his patents describes a neuro-progenitor produced from a somatic cell nuclear transfer (SCNT)-derived embryonic stem cell line. This embryonic stem cell line is created by transferring the nucleus of a human somatic cell into an enucleated human oocyte, allowing it to differentiate into various desired cell types. Another patent focuses on a similar process, emphasizing the versatility of the embryonic stem cell line derived from the nucleus-transferred oocyte.
Career Highlights
Hwang is associated with H Bion Co., Ltd., where he continues to advance his research in stem cell technology. His work has garnered attention for its innovative approach to cell differentiation and potential applications in treating various diseases.
Collaborations
Some of Hwang's notable coworkers include Sung-Il Roh and Woo-Suk Hwang, who have collaborated with him on various research projects. Their combined expertise contributes to the advancement of stem cell research and its applications.
Conclusion
Youn-Young Hwang is a key figure in the field of stem cell research, with innovative patents that pave the way for future medical advancements. His contributions are vital to the ongoing exploration of regenerative medicine and its potential to transform healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile